The Journal of Biomolecules, Pathogenesis and Therapeutics (JBPT) is an international, open-access, peer-reviewed journal dedicated to ethical, transparent, and high-quality publishing at the intersection of biomolecular science, disease mechanisms, and therapeutic innovation.
JBPT accelerates scientific progress by publishing rigorous basic, translational, and clinical research focusing on biomolecules involved in infectious, inflammatory, metabolic, genetic, and neoplastic disorders. The journal places heavy operational emphasis on deep mechanistic insights, advanced diagnostics, biomarker discoveries, and emerging therapeutic interventions.
Operated under the corporate backing of MSAR Institute, JBPT functions with complete and absolute editorial independence. The journal strictly adheres to the core principles of the Committee on Publication Ethics (COPE), enforces rigorous double-blind peer-review workflows, and maintains full open-access standards.
By eliminating financial barriers for researchers via our complete fee subsidy waiver program, JBPT ensures the uncompromised integrity, seamless accessibility, and global dissemination of authoritative scientific knowledge.
